Maher T M, Wells A U, Laurent G J
Centre for Respiratory Research, Rayne Institute, University College London, London, UK.
Eur Respir J. 2007 Nov;30(5):835-9. doi: 10.1183/09031936.00069307.
Idiopathic pulmonary fibrosis (IPF) is a devastating condition that carries a prognosis worse than that of many cancers. A recent classification of the idiopathic interstitial pneumonias has redefined the diagnostic criteria necessary to determine a diagnosis of IPF. The present authors believe that this redefinition is incorrect, relying as it does on subtle histological differences for the definition of separate disease categories. A further issue affecting IPF research is the polarisation of views around two competing pathogenetic hypotheses. One argues for the primacy of inflammation as the trigger that initiates fibrosis, and the other proposes that fibrosis arises as a consequence of chronic epithelial injury and failure of repair due to aberrant epithelial-mesenchymal interactions. The present authors believe that this schism is hampering understanding of IPF and skewing research priorities. It is argued here, instead, that abnormalities in multiple pathways involved in wound healing and inflammation lead to the development of idiopathic pulmonary fibrosis, and it is suggested that a new rationale for clinical classification and pathogenesis may be more productive in driving the search for novel therapies in the future.
特发性肺纤维化(IPF)是一种严重的疾病,其预后比许多癌症还要差。最近对特发性间质性肺炎的分类重新定义了诊断IPF所需的诊断标准。本文作者认为这种重新定义是不正确的,因为它依赖于细微的组织学差异来定义不同的疾病类别。影响IPF研究的另一个问题是围绕两种相互竞争的发病机制假说的观点两极分化。一种观点认为炎症是引发纤维化的首要因素,另一种观点则提出纤维化是慢性上皮损伤以及由于异常的上皮-间充质相互作用导致修复失败的结果。本文作者认为这种分歧阻碍了对IPF的理解,并扭曲了研究重点。相反,本文认为参与伤口愈合和炎症的多种途径异常会导致特发性肺纤维化的发展,并建议未来一种新的临床分类和发病机制理论可能会更有效地推动新型疗法的探索。